Combined inhibition of STAT and Notch signalling effectively suppresses tumourigenesis by inducing apoptosis and inhibiting proliferation, migration and invasion in glioblastoma cells
- Authors
- Tulip, Israt Jahan; Kim, Sung-Ok; Kim, Eun-Jung; Kim, Jaebong; Lee, Jae Yong; Kim, Hyunggee; Kim, Sung-Chan
- Issue Date
- 4-May-2021
- Publisher
- TAYLOR & FRANCIS LTD
- Keywords
- Glioblastoma; STAT signalling; Jagged; Notch signalling
- Citation
- ANIMAL CELLS AND SYSTEMS, v.25, no.3, pp.161 - 170
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- ANIMAL CELLS AND SYSTEMS
- Volume
- 25
- Number
- 3
- Start Page
- 161
- End Page
- 170
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/128054
- DOI
- 10.1080/19768354.2021.1942983
- ISSN
- 1976-8354
- Abstract
- Glioblastoma multiforme (GBM) is the most aggressive primary brain cancer and this is due to cancer cells being apoptosis-resistant and having increased cell proliferation, migration, invasion, and angiogenesis properties. Previous studies have indicated both STAT and Notch pathways being important for initiation and progression in GBM. In this work, we first studied the effects of STAT inhibitors on Notch signalling using small molecule STAT inhibitors. It was observed that STAT inhibitors surprisingly activated Notch signalling by inducing NICD and Notch target genes in GBM cells. Thus, we aimed to combine STAT inhibitor treatment with a Notch pathway inhibitor and study effects on GBM tumourigenesis. STAT5 inhibitor (Pimozide) and STAT3 inhibitor (S3I-201) were individually used in combination with gamma-secretase inhibitor (DAPT), an inhibitor of Notch signalling, in a panel of GBM cells for cell proliferation and epithelial plasticity changes. Compared with single-agent treatments, combinatorial treatments with the STAT and Notch inhibitors significantly increased apoptosis in the treated cells, impairing cell proliferation, migration, and invasion. These findings suggest that concurrent blocking of STAT and Notch signalling pathways could provide added therapeutic benefit for the treatment of glioblastoma.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biotechnology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.